Streamline MedTech (Beijing) Co., Ltd
HomePage-BookMark-简体中文
  • Home
  • Who We Are
  • Services
  • Why Streamline
  • Resources
  • Contact Us

Resources

Regulatory Systems
Useful Links
News and Events

News and Events

India: Indian Supreme Court seeks more oversight of DCGI’s clinical trial approvals

“India’s Supreme Court has called for all of the data supporting the approval of 162 clinical trials between July and August of this year by the Drug Controller General of India.”

Resources:  http://www.in-pharmatechnologist.com/Regulatory-Safety/Indian-Supreme-Court-seeks-more-oversight-of-DCGI-s-clinical-trial-approvals

Previous:China: Roller Coaster Path To Approval For Eliquis Uncovered By FDA Documents  Next:China: Will the Asian Clinical Trial Boom Turn to Bust
版权所有 © 2014-2024 思澜医药
京ICP备14009238号-1

Streamline MedTech (Beijing) Co., Ltd

Telephone: +86 10 6253 0237

本站基于 米拓企业建站系统 7.3.0 搭建